IP Verse

Botti & Ferrari patent opposition analysis

The comprehensive analysis of Botti & Ferrari opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Botti & Ferrari

Stay updated with the latest patent oppositions filed by Botti & Ferrari

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALS, INC.Jun 8, 2026BOTTI & FERRARI
EP4340842
Sotorasib Dosing RegimenAMGEN INC.May 26, 2026BOTTI & FERRARI
EP3700529
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIM INTERNATIONAL GMBHApr 9, 2026BOTTI & FERRARI
EP4316598
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 17, 2026BOTTI & FERRARI
EP4294395
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECH, INC.Dec 29, 2025BOTTI & FERRARI
EP3615541
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF. HOFFMANN-LA ROCHE AGDec 19, 2025BOTTI & FERRARI
EP3246047
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025BOTTI & FERRARI
EP4069254
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICAL CO., LTD.Jun 11, 2025BOTTI & FERRARI
EP3806664
Edible Confectionery Coatings Including Calcium CarbonateWM. WRIGLEY JR. COMPANYFeb 20, 2025BOTTI & FERRARI
EP3595667
Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMA S.P.A.Sep 17, 2024BOTTI & FERRARI

Top clients of Botti & Ferrari

Top companies who are the clients of Botti & Ferrari

CompanyTotal
BOTTI & FERRARI17
STM5
SESA1